782 related articles for article (PubMed ID: 19114099)
1. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
2. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
3. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
[TBL] [Abstract][Full Text] [Related]
4. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
6. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of ubidecarenone transdermal delivery systems.
Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
9. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
10. Effect of permeation enhancers and organic acids on the skin permeation of indapamide.
Ren C; Fang L; Li T; Wang M; Zhao L; He Z
Int J Pharm; 2008 Feb; 350(1-2):43-7. PubMed ID: 17888599
[TBL] [Abstract][Full Text] [Related]
11. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
Prasad Verma PR; Chandak AR
Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
[TBL] [Abstract][Full Text] [Related]
12. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of matrix type transdermal patch of ethinylestradiol and medroxyprogesterone acetate for anti-implantation activity in female Wistar rats.
Agrawal SS; Pruthi JK
Contraception; 2011 Nov; 84(5):533-8. PubMed ID: 22018130
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension.
Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F
Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
[TBL] [Abstract][Full Text] [Related]
18. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
20. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]